| Home | E-Submission | Sitemap | Editorial Office
top_img
Clinical and Molecular Hepatology Search > Browse Articles > Search



Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization
Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi
Clin Mol Hepatol.2016;22(4):458-465.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0054
                              
Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)
Hye Won Lee, Jun Yong Park, Beom Kyung Kim, Moon Young Kim, Jung Il Lee, Young Suk Kim, Ki Tae Yoon, Kwang-Hyub Han, Sang Hoon Ahn
Clin Mol Hepatol.2016;22(4):443-449.   Published online November 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0037
                              
Switch to tenofovir-based therapy or to continue adefovir-based therapy in CHB patients with suboptimal response to adefovir-based combination?
Byung-Cheol Song
Clin Mol Hepatol.2016;22(4):439-442.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0108
                              
New perspectives of biomarkers for the management of chronic hepatitis B
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol.2016;22(4):423-431.   Published online December 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0069
                                 Cited By 1
Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
Hong Joo Kim, Soo Kyung Park, Hyo Joon Yang, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Kyu Yong Choi
Clin Mol Hepatol.2016;22(3):350-358.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0019
                              
Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
Jaemin Lee, Sun Hong Yoo, Won Sohn, Hyung Woo Kim, Yong Sun Choi, Jung Ho Won, Jin Young Heo, Sang Jong Park, Young Min Park
Clin Mol Hepatol.2016;22(3):339-349.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0021
                                 Cited By 1
Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
Byoung Kuk Jang
Clin Mol Hepatol.2016;22(3):336-338.   Published online September 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0104
                              
Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
Hyeki Cho, Yuri Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Kook-Hwan Oh, Kyoungbun Lee, Syifa Mustika, Jung-Hwan Yoon, Yoon Jun Kim
Clin Mol Hepatol.2016;22(2):286-291.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0066
                                 Cited By 1
The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
Jeong Han Kim, Sung Hyun Ahn, Soon Young Ko, Won Hyeok Choe, Kyun-Hwan Kim, So Young Kwon
Clin Mol Hepatol.2016;22(2):241-249.   Published online June 15, 2016     
DOI: https://doi.org/10.3350/cmh.2015.0053
                                 Cited By 1
Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
Hyung Joon Yim
Clin Mol Hepatol.2016;22(2):238-240.   Published online June 25, 2016     
DOI: https://doi.org/10.3350/cmh.2016.0103
                              
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park
Clin Mol Hepatol.2016;22(1):152-159.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.152
                              
KASL clinical practice guidelines: management of chronic hepatitis B
Clin Mol Hepatol.2016;22(1):18-75.   Published online March 28, 2016     
DOI: https://doi.org/10.3350/cmh.2016.22.1.18
                                 Cited By 14
Erectile dysfunction in patients with liver disease related to chronic hepatitis B
Min Kim, Seul Young Kim, Woo Sun Rou, Se Woong Hwang, Byung Seok Lee
Clin Mol Hepatol.2015;21(4):352-357.   Published online December 24, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.4.352
                              
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
Jung Gil Park, Soo Young Park
Clin Mol Hepatol.2015;21(3):242-248.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.242
                                 Cited By 1
Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure
Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik
Clin Mol Hepatol.2015;21(3):232-241.   Published online September 30, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.3.232
                              
Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients
Joo An Hwang, Kee Bum Kim, Min Jae Yang, Sun Gyo Lim, Jae Chul Hwang, Jae Youn Cheong, Sung Won Cho, Soon Sun Kim
Clin Mol Hepatol.2015;21(2):131-140.   Published online June 26, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.2.131
                                 Cited By 2
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients
Sang Kyung Jung, Kyung-Ah Kim, So Young Ha, Hyun Kyo Lee, Young Doo Kim, Bu Hyun Lee, Woo Hyun Paik, Jong Wook Kim, Won Ki Bae, Nam-Hoon Kim, June Sung Lee, Yoon Jung Jwa
Clin Mol Hepatol.2015;21(1):41-48.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.41
                                 Cited By 3
The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
Clin Mol Hepatol.2015;21(1):32-40.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.32
                                 Cited By 7
Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
Han Na Choi, Jeong Eun Song, Hyeon Chul Lee, Hyeong Ho Jo, Chang Hyeong Lee, Byung Seok Kim
Clin Mol Hepatol.2015;21(1):24-31.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.24
                                 Cited By 4
Personalized treatment of hepatitis B
Anna S. Lok
Clin Mol Hepatol.2015;21(1):1-6.   Published online March 25, 2015     
DOI: https://doi.org/10.3350/cmh.2015.21.1.1
                                 Cited By 7
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C? [corrected-article]
Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Clin Mol Hepatol.2014;20(4):355-360.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.355
                              
Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
Clin Mol Hepatol.2014;20(4):347-354.   Published online December 24, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.4.347
                                 Cited By 4
Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir
EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee
Clin Mol Hepatol.2014;20(3):267-273.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.267
                                 Cited By 4
Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort
Sung Soo Ahn, Young Eun Chon, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jun Yong Park
Clin Mol Hepatol.2014;20(3):261-266.   Published online September 25, 2014     
DOI: https://doi.org/10.3350/cmh.2014.20.3.261
                                 Cited By 4
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data
Jeong Han Kim, Yun Jung Choi, Hee Won Moon, Soon Young Ko, Won Hyeok Choe, So Young Kwon
Clin Mol Hepatol.2013;19(4):409-416.   Published online December 28, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.4.409
                                 Cited By 1
Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients
Young Jip Kim, Kichan Kim, Sun Hyuk Hwang, Soon Sun Kim, Dami Lee, Jae Youn Cheong, Sung Won Cho
Clin Mol Hepatol.2013;19(3):300-304.   Published online September 30, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.3.300
                                 Cited By 9
Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients
Jeong Han Kim, Soon Young Ko, Won Hyeok Choe, So Young Kwon, Chang Hong Lee
Clin Mol Hepatol.2013;19(3):273-279.   Published online September 30, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.3.273
                              
Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade
Hyung Joon Yim, Seong Gyu Hwang
Clin Mol Hepatol.2013;19(3):195-209.   Published online September 30, 2013     
DOI: https://doi.org/10.3350/cmh.2013.19.3.195
                                 Cited By 12
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2012;18(2):109-162.   Published online June 26, 2012     
DOI: https://doi.org/10.3350/cmh.2012.18.2.109
                                 Cited By 75
Virologic response is not durable after adefovir discontinuation in lamivudine-resistant chronic hepatitis B patients
Young Kul Jung, Jong Eun Yeon, Kwang Gyun Lee, Eun Seok Jung, Jeong Han Kim, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Sun Ho Um, Ho Sang Ryu, Kwan Soo Byun
Korean J Hepatol.2011;17(4):261-267.   Published online December 26, 2011     
DOI: https://doi.org/10.3350/kjhep.2011.17.4.261
                                 Cited By 3
1 | 2 | 3 |
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.